Showing results (21-30 of 2,610) with videos related to
Sort By:
Pageof 261
Current Pharmaceutical Design|August 24, 2004
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?Pal Pacher, Valeria KecskemetiThe FEBS Journal|April 5, 2013
Modulating the endocannabinoid system in human health and disease--successes and failuresPál Pacher, George KunosJournal of Molecular Medicine (Berlin, Germany)|February 29, 2012
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegenerationPál Pacher, Ken MackieArteriosclerosis, Thrombosis, and Vascular Biology|March 17, 2012
Regulation of macrophage function by adenosineGyörgy Haskó, Pál PacherZeitschrift Fur Kardiologie|June 21, 2016
Prostaglandin E1 bridge to heart transplantation - methods, technique, resultsR Pacher, B StanekThe Plant Journal : for Cell and Molecular Biology|December 28, 2016
From classical mutagenesis to nuclease-based breeding - directing natural DNA repair for a natural end-productMichael Pacher, Holger PuchtaMedical Hypotheses|October 17, 2001
Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channelsP Pacher, Z UngvariProgress in Lipid Research|February 8, 2011
Is lipid signaling through cannabinoid 2 receptors part of a protective system?P Pacher, R MechoulamThe American Journal of Pathology|June 7, 2008
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human diseasePal Pacher, Csaba SzaboCardiovascular Drug Reviews|October 9, 2007
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitorsPál Pacher, Csaba SzabóPageof 261